Burcu Kesikli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Burcu Kesikli has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Nuray Yazihan
Pathophysiology Department, Faculty of Medicine, Ankara University, Ankara, Turkey
5 shared publications - Atakan Tanacan
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
4 shared publications - Dilek Sahin
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
4 shared publications - Ayse Gulcin Bastemur
Perinatology Division, Department of Obstetrics and Gynecology Eskişehir City Hospital Eskişehir Turkey
3 shared publications - İcLal Sena Gezer
Interdisciplinary Food, Metabolism and Clinical Nutrition Department, Institute of Health Sciences, Ankara University, Ankara, Turkey
3 shared publications - Pelin Aribal Ayral
ANKARA UNIVERSITY, ANKARA FACULTY OF MEDICINE
2 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by Springer Nature in Nutrire
- Vol. 51 (2) , 100
Evaluation of dietary inflammatory index and dietary antioxidant capacity with maternal inflammatory and oxidative markers in preeclampsia
- 24 July 2026
- Published by Springer Nature in Nutrire
- Vol. 51 (2) , 100
Open AccessEvaluation of dietary inflammatory index and dietary antioxidant capacity with maternal inflammatory and oxidative markers in preeclampsia
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (4) , e20251979
Relation of inflammatory and oxidative biomarkers associated with relapse in pregnant women diagnosed with multiple sclerosis
SUMMARY OBJECTIVE: The aim of this study was to examine the relationship between inflammatory mediators (tumor necrosis factor-alpha, interleukin-6, and interleukin-10), oxidative stress parameters, and obstetric-neonatal outcomes in maternal blood of pregnant patients with multiple sclerosis and healthy pregnant patients, and to identify biomarkers that may be useful in predicting relapse in pregnant patients with multiple sclerosis. METHODS: This prospective, single-center study was conducted at Ankara City Hospital between July 2024 and May 2025 and included a total of 72 patients: 36 pregnant women diagnosed with multiple sclerosis and 36 healthy pregnant women as the control group. The patients with multiple sclerosis were further divided into two groups: those who experienced relapses during pregnancy and those who did not. Clinical and demographic data, biochemical tests (interleukin-6, interleukin-10, tumor necrosis factor-alpha, total antioxidant status, and total oxidant status), and obstetric and neonatal outcomes were recorded. Data were analyzed statistically using SPSS 22.0, and appropriate statistical tests and correlation analyses were applied. RESULTS: Levels of interleukin-6, interleukin-10, tumor necrosis factor-alpha, total oxidant status, and total antioxidant status were significantly higher in patients with multiple sclerosis compared to controls (p<0.01). These parameters were even more elevated in patients who experienced relapses. Receiver operating characteristic analysis demonstrated that cut-off values of 237.8 pg/mL for tumor necrosis factor-alpha and 1.75 for interleukin-6/interleukin-10 provided high sensitivity and specificity in predicting multiple sclerosis relapse. CONCLUSION: Inflammatory and oxidative stress markers were elevated in pregnant women with multiple sclerosis, and tumor necrosis factor-alpha levels and the interleukin-6/interleukin-10 ratio were identified as potential biomarkers for predicting disease relapse.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (4) , e20251979
Open AccessRelation of inflammatory and oxidative biomarkers associated with relapse in pregnant women diagnosed with multiple sclerosis
SUMMARY OBJECTIVE: The aim of this study was to examine the relationship between inflammatory mediators (tumor necrosis factor-alpha, interleukin-6, and interleukin-10), oxidative stress parameters, and obstetric-neonatal outcomes in maternal blood of pregnant patients with multiple sclerosis and healthy pregnant patients, and to identify biomarkers that may be useful in predicting relapse in pregnant patients with multiple sclerosis. METHODS: This prospective, single-center study was conducted at Ankara City Hospital between July 2024 and May 2025 and included a total of 72 patients: 36 pregnant women diagnosed with multiple sclerosis and 36 healthy pregnant women as the control group. The patients with multiple sclerosis were further divided into two groups: those who experienced relapses during pregnancy and those who did not. Clinical and demographic data, biochemical tests (interleukin-6, interleukin-10, tumor necrosis factor-alpha, total antioxidant status, and total oxidant status), and obstetric and neonatal outcomes were recorded. Data were analyzed statistically using SPSS 22.0, and appropriate statistical tests and correlation analyses were applied. RESULTS: Levels of interleukin-6, interleukin-10, tumor necrosis factor-alpha, total oxidant status, and total antioxidant status were significantly higher in patients with multiple sclerosis compared to controls (p<0.01). These parameters were even more elevated in patients who experienced relapses. Receiver operating characteristic analysis demonstrated that cut-off values of 237.8 pg/mL for tumor necrosis factor-alpha and 1.75 for interleukin-6/interleukin-10 provided high sensitivity and specificity in predicting multiple sclerosis relapse. CONCLUSION: Inflammatory and oxidative stress markers were elevated in pregnant women with multiple sclerosis, and tumor necrosis factor-alpha levels and the interleukin-6/interleukin-10 ratio were identified as potential biomarkers for predicting disease relapse.
- Open Access
- 14 May 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-9
The influence of dietary choices: investigation of the relationship dietary inflammatory index and fetal growth restriction
Fetal growth restriction (FGR) is characterized by the fetus’s inability to reach its growth potential and affecting approximately 10% of the population. The etiology of late-onset FGR, which occurs after 32 weeks, is unclear but may be influenced by maternal weight. A proinflammatory diet can cause chronic inflammation and, Dietary Inflammatory Index (DII) was developed to evaluate of the diet’s impact on inflammation. A high DII indicates a pro-inflammatory diet, known to increase serum inflammatory markers, with oxidative stress playing a key role in inflammatory diseases. The study aimed to investigate the correlation between maternal DII, total oxidant status (TOS), total antioxidant status (TAS), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-α) levels in FGR-diagnosed pregnant women. This prospective-observational study included FGR-diagnosed pregnant women and healthy pregnant women with gestational ages of 32–38 weeks (n = 23 per group). Chronic diseases, hypertension, fetal anomalies, membrane ruptures, and multiple pregnancies were excluded. The DII was calculated using the BeBiS-9 program based on 3-day dietary records kept by an expert dietician. Blood samples were collected, centrifuged, and analyzed for IL-6, TNF-α, IL-10, TAS, and TOS. The study group had significantly higher DII scores (p < 0.001), lower energy (p = 0.004), carbohydrate (p = 0.002), protein (p = 0.011), fiber (p < 0.001) intake than the control group. TNF-α levels were elevated in the FGR group (p < 0.001), while IL-6 levels were higher but not statistically significant (p = 0.06). IL-10 levels were lower in the study group (p = 0.05). TAS, TOS, and TAS/TOS levels showed no significant differences between groups. Logistic regression indicated a 62% increase in FGR probability with higher DII levels (p = 0.001, CI 1.209–2.195). Correlation analysis revealed a strong positive correlation between DII and maternal serum TNF-α (r = 0.375, p = 0.01) and a strong negative correlation between birth weight and TNF-α (r=-0.478, p < 0.001) and DII (r=-0.446, p = 0.002). This study showed that a pro-inflammatory maternal diet increased dietary inflammatory index and increased maternal inflammatory markers, and this was more significant in fetuses with FGR than in normal weight fetuses.
- 14 May 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-9
Open AccessThe influence of dietary choices: investigation of the relationship dietary inflammatory index and fetal growth restriction
Fetal growth restriction (FGR) is characterized by the fetus’s inability to reach its growth potential and affecting approximately 10% of the population. The etiology of late-onset FGR, which occurs after 32 weeks, is unclear but may be influenced by maternal weight. A proinflammatory diet can cause chronic inflammation and, Dietary Inflammatory Index (DII) was developed to evaluate of the diet’s impact on inflammation. A high DII indicates a pro-inflammatory diet, known to increase serum inflammatory markers, with oxidative stress playing a key role in inflammatory diseases. The study aimed to investigate the correlation between maternal DII, total oxidant status (TOS), total antioxidant status (TAS), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-α) levels in FGR-diagnosed pregnant women. This prospective-observational study included FGR-diagnosed pregnant women and healthy pregnant women with gestational ages of 32–38 weeks (n = 23 per group). Chronic diseases, hypertension, fetal anomalies, membrane ruptures, and multiple pregnancies were excluded. The DII was calculated using the BeBiS-9 program based on 3-day dietary records kept by an expert dietician. Blood samples were collected, centrifuged, and analyzed for IL-6, TNF-α, IL-10, TAS, and TOS. The study group had significantly higher DII scores (p < 0.001), lower energy (p = 0.004), carbohydrate (p = 0.002), protein (p = 0.011), fiber (p < 0.001) intake than the control group. TNF-α levels were elevated in the FGR group (p < 0.001), while IL-6 levels were higher but not statistically significant (p = 0.06). IL-10 levels were lower in the study group (p = 0.05). TAS, TOS, and TAS/TOS levels showed no significant differences between groups. Logistic regression indicated a 62% increase in FGR probability with higher DII levels (p = 0.001, CI 1.209–2.195). Correlation analysis revealed a strong positive correlation between DII and maternal serum TNF-α (r = 0.375, p = 0.01) and a strong negative correlation between birth weight and TNF-α (r=-0.478, p < 0.001) and DII (r=-0.446, p = 0.002). This study showed that a pro-inflammatory maternal diet increased dietary inflammatory index and increased maternal inflammatory markers, and this was more significant in fetuses with FGR than in normal weight fetuses.
- 23 June 2023
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 70 (3) , 303-308
Effect of ascorbic acid on collagen and some inflammatory mediators in rats
Musculoskeletal injuries as a kind of traumas that the human body is exposed to, adversely affect the quality of life and workforce of individuals due to restriction of movement function. This study was aimed to evaluate the effects of dose-dependent ascorbic acid administration on the repair process after gastrocnemius muscle injury in rats. In this study, 5-month-old 66 male Wistar Albino rats were used and rats were randomized to 6 groups (n = 11/group). A linear incision was made in the gastrocnemius muscle of thirty-three animals included in the muscle injury groups. Ascorbic acid (5-10 mg/kg/day) was administered to the four groups intraperitoneally just after surgery once a day. Animals were sacrificed twenty-one days later. Blood and tissue samples were used for cytokine, collagen, and histological measurements. It was found that ascorbic acid reduced serum IL-6 and muscle tissue TNF-α levels, and increased liver tissue IL-10 levels. Muscle tissue collagen levels were not statistically different between the groups in parallel with our histological results. In our study, it was demonstrated that vitamin C has effects on inflammatory mediators during muscle tissue repair to explain mechanism detailed molecular analyzes are needed.
- 23 June 2023
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 70 (3) , 303-308
Effect of ascorbic acid on collagen and some inflammatory mediators in rats
Musculoskeletal injuries as a kind of traumas that the human body is exposed to, adversely affect the quality of life and workforce of individuals due to restriction of movement function. This study was aimed to evaluate the effects of dose-dependent ascorbic acid administration on the repair process after gastrocnemius muscle injury in rats. In this study, 5-month-old 66 male Wistar Albino rats were used and rats were randomized to 6 groups (n = 11/group). A linear incision was made in the gastrocnemius muscle of thirty-three animals included in the muscle injury groups. Ascorbic acid (5-10 mg/kg/day) was administered to the four groups intraperitoneally just after surgery once a day. Animals were sacrificed twenty-one days later. Blood and tissue samples were used for cytokine, collagen, and histological measurements. It was found that ascorbic acid reduced serum IL-6 and muscle tissue TNF-α levels, and increased liver tissue IL-10 levels. Muscle tissue collagen levels were not statistically different between the groups in parallel with our histological results. In our study, it was demonstrated that vitamin C has effects on inflammatory mediators during muscle tissue repair to explain mechanism detailed molecular analyzes are needed.
- Open Access
- 5 May 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (9) , 5438-5445
Maternal selenium status plays a crucial role on clinical outcomes of pregnant women with COVID‐19 infection
Adequate maternal selenium level is essential for immune response and healthy pregnancy. This study aimed to shed light on the selenium status of pregnant women with COVID‐19 and the effects of potential deficiency in serum selenium levels. Totally 141 pregnant women, 71 of them were COVID‐19 patients, in different trimesters were included in the study. Maternal serum selenium levels, demographic and clinical parameters were determined. Serum selenium levels of pregnant women in the second (p: .0003) and third (p: .001) trimesters with COVID‐19 were significantly lower than in the healthy group. Maternal selenium level was found to be negatively correlated with gestational week (p < .0001, r: −.541), D‐dimer (p: .0002, r: −.363) and interleukin‐6 (IL‐6) level (p: .02, r: −.243). In the second trimester, serum selenium level positively correlated with white blood cell (p: .002, r: .424), neutrophil (p: .006, r: .39), lymphocyte (p: .004, r: .410) count and hemoglobin (p: .02, r: .323), hematocrit (p: .008, r: .38) status. In the third trimester, it was found that maternal selenium level positively correlated with monocyte (p: .04, r: .353) and negatively correlated with C‐reactive protein level (p: .03, r: −.384). Serum selenium level was gradually decreased during the pregnancy period, however, this natural decrease was enhanced together with COVID‐19 infection. The reason might be increased selenium needs depended on the immune response against infection. The decrease in maternal selenium level was found to be related to IL‐6 and D‐dimer levels, which indicate selenium's role in disease progression.
- 5 May 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (9) , 5438-5445
Open AccessMaternal selenium status plays a crucial role on clinical outcomes of pregnant women with COVID‐19 infection
Adequate maternal selenium level is essential for immune response and healthy pregnancy. This study aimed to shed light on the selenium status of pregnant women with COVID‐19 and the effects of potential deficiency in serum selenium levels. Totally 141 pregnant women, 71 of them were COVID‐19 patients, in different trimesters were included in the study. Maternal serum selenium levels, demographic and clinical parameters were determined. Serum selenium levels of pregnant women in the second (p: .0003) and third (p: .001) trimesters with COVID‐19 were significantly lower than in the healthy group. Maternal selenium level was found to be negatively correlated with gestational week (p < .0001, r: −.541), D‐dimer (p: .0002, r: −.363) and interleukin‐6 (IL‐6) level (p: .02, r: −.243). In the second trimester, serum selenium level positively correlated with white blood cell (p: .002, r: .424), neutrophil (p: .006, r: .39), lymphocyte (p: .004, r: .410) count and hemoglobin (p: .02, r: .323), hematocrit (p: .008, r: .38) status. In the third trimester, it was found that maternal selenium level positively correlated with monocyte (p: .04, r: .353) and negatively correlated with C‐reactive protein level (p: .03, r: −.384). Serum selenium level was gradually decreased during the pregnancy period, however, this natural decrease was enhanced together with COVID‐19 infection. The reason might be increased selenium needs depended on the immune response against infection. The decrease in maternal selenium level was found to be related to IL‐6 and D‐dimer levels, which indicate selenium's role in disease progression.